Electrospun scaffolds have been broadly
studied to enhance bone regeneration because of the ability to simulate
the structure and biological functions of the extracellular matrix.
Polydopamine (PDA) is used to coat various surfaces at a slightly
basic pH (8–8.5) and spontaneously reacts with nucleophilic
functional groups. It is suitable for surface modifications of scaffolds
correlated with bone formation. E7 is a newly discovered peptide with
specific affinity for bone marrow mesenchymal stem cells (BMSCs).
It can be useful for recruiting stem cells. Here, electrospun silk
fibroin (SF) scaffolds were fabricated, and PDA was used for surface
modification followed by grafting E7 (SF–PDA–E7). These
composite SF–PDA–E7 electrospun scaffolds improved hydrophilicity,
facilitated cell proliferation and adhesion, and boosted the osteogenic
differentiation of BMSCs by creating osteoinduction conditions under
the synergistic effects of PDA and E7. Moreover, the scaffolds showed
high efficiency for recruiting BMSCs induced by E7 both in vitro and
in vivo, which was associated with the SDF-1α/CXCR4 axis and
the p38, extracellular signal-related kinase, and Akt signal transduction
pathways. These functionalized electrospun scaffolds promoted regeneration
of bone in the rat calvarial bone defect model. In general, this study
verified that PDA could be a simple and efficient method for surface
modification, and E7-grafted PDA-modified SF electrospun scaffolds
were suitable for bone tissue engineering.
IntroductionBone tissue engineering has become one of the most effective methods to treat bone defects. Silk fibroin (SF) is a natural protein with no physiological activities, which has features such as good biocompatibility and easy processing and causes minimal inflammatory reactions in the body. Scaffolds prepared by electrospinning SF can be used in bone tissue regeneration and repair. Graphene oxide (GO) is rich in functional groups, has good biocompatibility, and promotes osteogenic differentiation of stem cells, while bone morphogenetic protein-2 (BMP-2) polypeptide has an advantage in promoting osteogenesis induction. In this study, we attempted to graft BMP-2 polypeptide onto GO and then bonded the functionalized GO onto SF electrospun scaffolds through electrostatic interactions. The main purpose of this study was to further improve the biocompatibility of SF electrospun scaffolds, which could promote the osteogenic differentiation of bone marrow mesenchymal stem cells and the repair of bone tissue defects.Materials and methodsThe successful synthesis of GO and functionalized GO was confirmed by transmission electron microscope, X-ray photoelectron spectroscopy, and thermogravimetric analysis. Scanning electron microscopy, atomic force microscopy, mechanical test, and degradation experiment confirmed the preparation of SF electrospun scaffolds and the immobilization of GO on the fibers. In vitro experiment was used to verify the biocompatibility of the composite scaffolds, and in vivo experiment was used to prove the repairing ability of the composite scaffolds for bone defects.ResultsWe successfully fabricated the composite scaffolds, which enhanced biocompatibility, not only promoting cell adhesion and proliferation but also greatly enhancing in vitro osteogenic differentiation of bone marrow stromal cells using either an osteogenic or non-osteogenic medium. Furthermore, transplantation of the composite scaffolds significantly promoted in vivo bone formation in critical-sized calvarial bone defects.ConclusionThese findings suggested that the incorporation of BMP-2 polypeptide-functionalized GO into chitosan-coated SF electrospun scaffolds was a viable strategy for fabricating excellent scaffolds that enhance the regeneration of bone defects.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.